Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Biomaterials. 2009 Nov 26;31(6):1444. doi: 10.1016/j.biomaterials.2009.11.016

Figure 8.

Figure 8

Anti-fungal activity of CMC-dextran gels containing AmB suspension, dextran-CHO33-AmB62.5 and dextran-CHO66-AmB62.5, each formulation containing 1.5 mg AmB/mL upon gelation of CMC-Dextran gels. The release media (YNB) was changed and tested each day and stored shaking in darkness at 150 rpm at 37°C between tests. The lower detectable limit of candidal survival was 0.2 %.